Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...
Voiso enables Contact Center Success with Metric-Driven Tools
New York, New York - Voiso, a global leader in contact center software, is redefining how businesses leverage data to ...